Firm Gsk
Sort by
6 items
-
Business - MarketWatch
GSK settles vast majority of Zantac claims for $2.2 billion
The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer3 hours ago -
Top stories - BBC News
UK firm GSK to pay $2.2bn over Zantac cancer claims
The UK-based firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.8 hours ago - United Kingdom -
Business - Financial Times
GSK shares jump after drugmaker reaches $2.2bn Zantac settlement
Agreement over heartburn medicine should help to resolve concerns hanging over UK drugmaker17 hours ago -
Business - The Wall Street Journal
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.18 hours ago